vs
Side-by-side financial comparison of Incyte (INCY) and KeyCorp (KEY). Click either name above to swap in a different company.
KeyCorp is the larger business by last-quarter revenue ($2.0B vs $1.3B, roughly 1.6× Incyte). KeyCorp runs the higher net margin — 25.4% vs 23.8%, a 1.6% gap on every dollar of revenue. On growth, KeyCorp posted the faster year-over-year revenue change (131.8% vs 20.9%). Over the past eight quarters, KeyCorp's revenue compounded faster (14.4% CAGR vs 10.4%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Key is a Japanese visual novel studio known for making dramatic and plot-oriented titles. It was formed on July 21, 1998, as a brand under the publisher Visual Arts, and is located in Kita, Osaka.
INCY vs KEY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $2.0B |
| Net Profit | $303.3M | $510.0M |
| Gross Margin | — | — |
| Operating Margin | 23.7% | 32.3% |
| Net Margin | 23.8% | 25.4% |
| Revenue YoY | 20.9% | 131.8% |
| Net Profit YoY | 91.7% | 309.0% |
| EPS (diluted) | $1.47 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.5B | $2.0B | ||
| Q3 25 | $1.4B | $1.9B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.1B | $1.8B | ||
| Q4 24 | $1.2B | $865.0M | ||
| Q3 24 | $1.1B | $695.0M | ||
| Q2 24 | $1.0B | $1.5B |
| Q1 26 | $303.3M | — | ||
| Q4 25 | $299.3M | $510.0M | ||
| Q3 25 | $424.2M | $489.0M | ||
| Q2 25 | $405.0M | $425.0M | ||
| Q1 25 | $158.2M | $405.0M | ||
| Q4 24 | $201.2M | $-244.0M | ||
| Q3 24 | $106.5M | $-410.0M | ||
| Q2 24 | $-444.6M | $274.0M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | — | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | — | ||
| Q2 24 | 92.7% | — |
| Q1 26 | 23.7% | — | ||
| Q4 25 | 22.3% | 32.3% | ||
| Q3 25 | 32.5% | 31.8% | ||
| Q2 25 | 43.6% | 29.3% | ||
| Q1 25 | 19.5% | 29.0% | ||
| Q4 24 | 25.6% | -92.6% | ||
| Q3 24 | 12.8% | -72.8% | ||
| Q2 24 | -45.8% | 22.0% |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 19.9% | 25.4% | ||
| Q3 25 | 31.1% | 25.8% | ||
| Q2 25 | 33.3% | 23.1% | ||
| Q1 25 | 15.0% | 22.8% | ||
| Q4 24 | 17.1% | -54.7% | ||
| Q3 24 | 9.4% | -59.0% | ||
| Q2 24 | -42.6% | 18.0% |
| Q1 26 | $1.47 | — | ||
| Q4 25 | $1.46 | $0.43 | ||
| Q3 25 | $2.11 | $0.41 | ||
| Q2 25 | $2.04 | $0.35 | ||
| Q1 25 | $0.80 | $0.33 | ||
| Q4 24 | $0.90 | $-0.30 | ||
| Q3 24 | $0.54 | $-0.47 | ||
| Q2 24 | $-2.04 | $0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $10.2B |
| Total DebtLower is stronger | — | $9.9B |
| Stockholders' EquityBook value | $5.6B | $20.4B |
| Total Assets | $7.3B | $184.4B |
| Debt / EquityLower = less leverage | — | 0.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $10.2B | ||
| Q3 25 | $2.5B | $13.3B | ||
| Q2 25 | $2.0B | $11.6B | ||
| Q1 25 | $1.9B | $15.3B | ||
| Q4 24 | $1.7B | $17.5B | ||
| Q3 24 | $1.3B | $22.8B | ||
| Q2 24 | $987.3M | $15.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | $9.9B | ||
| Q3 25 | — | $10.9B | ||
| Q2 25 | — | $12.1B | ||
| Q1 25 | — | $12.4B | ||
| Q4 24 | — | $12.1B | ||
| Q3 24 | — | $15.7B | ||
| Q2 24 | — | $16.9B |
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.2B | $20.4B | ||
| Q3 25 | $4.7B | $20.1B | ||
| Q2 25 | $4.2B | $19.5B | ||
| Q1 25 | $3.7B | $19.0B | ||
| Q4 24 | $3.4B | $18.2B | ||
| Q3 24 | $3.2B | $16.9B | ||
| Q2 24 | $3.0B | $14.8B |
| Q1 26 | $7.3B | — | ||
| Q4 25 | $7.0B | $184.4B | ||
| Q3 25 | $6.3B | $187.4B | ||
| Q2 25 | $5.8B | $185.5B | ||
| Q1 25 | $5.7B | $188.7B | ||
| Q4 24 | $5.4B | $187.2B | ||
| Q3 24 | $5.0B | $189.8B | ||
| Q2 24 | $4.7B | $187.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.49× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | 0.93× | ||
| Q2 24 | — | 1.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.2B |
| Free Cash FlowOCF − Capex | — | $2.1B |
| FCF MarginFCF / Revenue | — | 104.8% |
| Capex IntensityCapex / Revenue | — | 5.3% |
| Cash ConversionOCF / Net Profit | — | 4.33× |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.5B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $543.3M | $2.2B | ||
| Q3 25 | $559.4M | $396.0M | ||
| Q2 25 | $44.7M | $1.2B | ||
| Q1 25 | $266.1M | $-140.0M | ||
| Q4 24 | $381.2M | $664.0M | ||
| Q3 24 | $310.9M | $-1.2B | ||
| Q2 24 | $-575.6M | $-217.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $367.0M | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $-150.0M | ||
| Q4 24 | — | $599.0M | ||
| Q3 24 | — | $-1.2B | ||
| Q2 24 | — | $-230.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 104.8% | ||
| Q3 25 | — | 19.4% | ||
| Q2 25 | — | 65.8% | ||
| Q1 25 | — | -8.5% | ||
| Q4 24 | — | 69.2% | ||
| Q3 24 | — | -175.8% | ||
| Q2 24 | — | -15.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.3% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | 4.33× | ||
| Q3 25 | 1.32× | 0.81× | ||
| Q2 25 | 0.11× | 2.90× | ||
| Q1 25 | 1.68× | -0.35× | ||
| Q4 24 | 1.89× | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | -0.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
